HF
QTTB icon

HRT Financial’s Q32 Bio QTTB Stock Holding History

HRT Financial’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,698
Closed -$81K – 4916
2025
Q4 		$81K Buy
24,698
+9,862
+66% +$27.9K ﹤0.01% 2816
2025
Q3 		$29K Buy
+14,836
New +$28.5K ﹤0.01% 2665
2022
Q3 		– Sell
-800
Closed -$28K – 3623
2022
Q2 		$28K Buy
+800
New +$27.3K ﹤0.01% 2572
2022
Q1 		– Sell
-2,584
Closed -$169K – 4004
2021
Q4 		$169K Buy
2,584
+858
+50% +$83.3K ﹤0.01% 2595
2021
Q3 		$244K Buy
+1,726
New +$220K ﹤0.01% 2552
2021
Q1 		– Sell
-831
Closed -$168K – 3237
2020
Q4 		$168K Sell
831
-526
-39% -$102K ﹤0.01% 1539
2020
Q3 		$261K Buy
+1,357
New +$304K 0.01% 1228

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRT Financial's QTTB Position: Q1 2026 in Review

HRT Financial sold out of Q32 Bio (QTTB) in Q1 2026, closing a stake of 24,698 shares — an estimated $81K sold.

HRT Financial first reported a position in QTTB in Q3 2020 and held it in 7 quarters. The position peaked at $261K in Q3 2020. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • HRT Financial reported no remaining Q32 Bio position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 24,698 Q32 Bio shares in Q1 2026, an estimated $81K.
  • HRT Financial first reported a position in Q32 Bio in Q3 2020 and held it in 7 quarters.
  • HRT Financial's Q32 Bio position peaked at $261K in Q3 2020.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.